UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 262

Sortiert nach

Current treatment of antiphospholipid syndrome: lights and shadows

Nature reviews. Rheumatology, 2015-10, Vol.11 (10), p.586

2015

Volltextzugriff (PDF)

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

Journal of autoimmunity, 2018-08, Vol.92, p.1-11

2018

Volltextzugriff (PDF)

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry

Autoimmunity reviews, 2016-12, Vol.15 (12), p.1120-1124

2016

Volltextzugriff (PDF)

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”

Autoimmunity reviews, 2022-04, Vol.21 (4), p.103055, Article 103055

2022

Volltextzugriff (PDF)

Catastrophic antiphospholipid syndrome: Updated diagnostic algorithms

Autoimmunity reviews, 2010-12, Vol.10 (2), p.74-79

2010

Volltextzugriff (PDF)

Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab

Autoimmunity reviews, 2013-09, Vol.12 (11), p.1085-1090

2013

Volltextzugriff (PDF)

Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide

Frontiers in immunology, 2020-06, Vol.11, p.865-865

2020

Volltextzugriff (PDF)

14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome

Autoimmunity reviews, 2014-07, Vol.13 (7), p.699-707

2014

Volltextzugriff (PDF)

TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA

Retina (Philadelphia, Pa.), 2018-07, Vol.38 (7), p.1361

2018

Volltextzugriff (PDF)

Immunosuppression and Chagas disease: a management challenge

PLoS neglected tropical diseases, 2013-01, Vol.7 (1), p.e1965

2013

Volltextzugriff (PDF)

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

Respiratory research, 2022-02, Vol.23 (1), p.37-37, Article 37

2022

Volltextzugriff (PDF)

Using machine learning to estimate the effect of racial segregation on COVID-19 mortality in the United States

Proceedings of the National Academy of Sciences - PNAS, 2021-02, Vol.118 (7)

Torrats-Espinosa, Gerard

2021

Volltextzugriff (PDF)

Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization

Acta ophthalmologica (Oxford, England), 2015-09, Vol.93 (6), p.561-567

2015

Volltextzugriff (PDF)

Management of refractory cases of catastrophic antiphospholipid syndrome

Autoimmunity reviews, 2011-09, Vol.10 (11), p.664-668

2011

Volltextzugriff (PDF)

Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study

Arthritis research & therapy, 2022-11, Vol.24 (1), p.253-253, Article 253

2022

Volltextzugriff (PDF)

Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center

Arthritis research & therapy, 2022-04, Vol.24 (1), p.91-91, Article 91

2022

Volltextzugriff (PDF)

Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry

Lupus, 2022-02, Vol.31 (2), p.194-201

2022

Volltextzugriff (PDF)

The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study

Arthritis research & therapy, 2022-01, Vol.24 (1), p.9-9, Article 9

2022

Volltextzugriff (PDF)

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases

Autoimmunity reviews, 2015-05, Vol.14 (5), p.387-395

2015

Volltextzugriff (PDF)

Tocilizumab treatment for refractory uveitis-related cystoid macular edema

Graefe's archive for clinical and experimental ophthalmology, 2013-11, Vol.251 (11), p.2627-2632

2013

Volltextzugriff (PDF)

Catastrophic antiphospholipid syndrome: an update

Panminerva medica, 2017-09, Vol.59 (3), p.254

2017

Volltextzugriff (PDF)

Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk

Frontiers in immunology, 2021-10, Vol.12, p.754469

2021

Volltextzugriff (PDF)

Using a natural experiment to estimate the electoral consequences of terrorist attacks

Proceedings of the National Academy of Sciences - PNAS, 2018-10, Vol.115 (42), p.10624-10629

2018

Volltextzugriff (PDF)

Combination of old and new drugs to improve renal outcome in SLE patients

Rheumatology (Oxford, England), 2024-02, Vol.63 (2), p.271-272

2024

Volltextzugriff (PDF)

Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center

Autoimmunity reviews, 2016-01, Vol.15 (1), p.9-15

2016

Volltextzugriff (PDF)

1 – 25 von 262

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(253)
Mit Volltextzugriff
(204)

Sprache

Englisch
(249)
Japanisch
(42)
Spanisch
(18)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(257)
Science & Technology
(241)
Life Sciences & Biomedicine
(232)
Female
(157)
Male
(132)
Adult
(105)
Middle Aged
(95)
Rheumatology
(89)
Immunology
(56)
Aged
(52)
Antiphospholipid Syndrome
(50)
Antiphospholipid Syndrome - Complications
(40)
Risk Factors
(40)
General & Internal Medicine
(39)
Treatment Outcome
(39)
Pregnancy
(38)
Medicine, General & Internal
(37)
Retrospective Studies
(36)
Biological And Medical Sciences
(33)
Young Adult
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current treatment of antiphospholipid syndrome: lights and shadows

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”

Catastrophic antiphospholipid syndrome: Updated diagnostic algorithms

Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab

Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide

14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome

TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA

Immunosuppression and Chagas disease: a management challenge

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

Using machine learning to estimate the effect of racial segregation on COVID-19 mortality in the United States

Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization

Management of refractory cases of catastrophic antiphospholipid syndrome

Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study

Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center

Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry

The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases

Tocilizumab treatment for refractory uveitis-related cystoid macular edema

Catastrophic antiphospholipid syndrome: an update

Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk

Using a natural experiment to estimate the electoral consequences of terrorist attacks

Combination of old and new drugs to improve renal outcome in SLE patients

Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center

Aktive Filter

Suchergebnisse filtern